424 related articles for article (PubMed ID: 21956718)
21. Nuclear RNA transcript levels modulate nucleocytoplasmic distribution of ALS/FTD-associated protein FUS.
Tsai YL; Mu YC; Manley JL
Sci Rep; 2022 May; 12(1):8180. PubMed ID: 35581240
[TBL] [Abstract][Full Text] [Related]
22. Lost in local translation: TDP-43 and FUS in axonal/neuromuscular junction maintenance and dysregulation in amyotrophic lateral sclerosis.
Piol D; Robberechts T; Da Cruz S
Neuron; 2023 May; 111(9):1355-1380. PubMed ID: 36963381
[TBL] [Abstract][Full Text] [Related]
23. Nuclear-import receptors as gatekeepers of pathological phase transitions in ALS/FTD.
Khalil B; Linsenmeier M; Smith CL; Shorter J; Rossoll W
Mol Neurodegener; 2024 Jan; 19(1):8. PubMed ID: 38254150
[TBL] [Abstract][Full Text] [Related]
24. Mutated FUS in familial amyotrophic lateral sclerosis involves multiple hnRNPs in the formation of neuronal cytoplasmic inclusions.
Honda H; Yoshimura M; Arahata H; Yagita K; Sadashima S; Hamasaki H; Shijo M; Koyama S; Noguchi H; Sasagasako N
J Neuropathol Exp Neurol; 2023 Feb; 82(3):231-241. PubMed ID: 36592411
[TBL] [Abstract][Full Text] [Related]
25. Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions.
Farrawell NE; Lambert-Smith IA; Warraich ST; Blair IP; Saunders DN; Hatters DM; Yerbury JJ
Sci Rep; 2015 Aug; 5():13416. PubMed ID: 26293199
[TBL] [Abstract][Full Text] [Related]
26. RNA and the RNA-binding protein FUS act in concert to prevent TDP-43 spatial segregation.
Demongin C; Tranier S; Joshi V; Ceschi L; Desforges B; Pastré D; Hamon L
J Biol Chem; 2024 Mar; 300(3):105716. PubMed ID: 38311174
[TBL] [Abstract][Full Text] [Related]
27. FUS-SMN protein interactions link the motor neuron diseases ALS and SMA.
Yamazaki T; Chen S; Yu Y; Yan B; Haertlein TC; Carrasco MA; Tapia JC; Zhai B; Das R; Lalancette-Hebert M; Sharma A; Chandran S; Sullivan G; Nishimura AL; Shaw CE; Gygi SP; Shneider NA; Maniatis T; Reed R
Cell Rep; 2012 Oct; 2(4):799-806. PubMed ID: 23022481
[TBL] [Abstract][Full Text] [Related]
28. ALS-linked FUS mutations confer loss and gain of function in the nucleus by promoting excessive formation of dysfunctional paraspeckles.
An H; Skelt L; Notaro A; Highley JR; Fox AH; La Bella V; Buchman VL; Shelkovnikova TA
Acta Neuropathol Commun; 2019 Jan; 7(1):7. PubMed ID: 30642400
[TBL] [Abstract][Full Text] [Related]
29. Amyotrophic Lateral Sclerosis, FUS and Protein Synthesis Defects.
Assoni AF; Foijer F; Zatz M
Stem Cell Rev Rep; 2023 Apr; 19(3):625-638. PubMed ID: 36515764
[TBL] [Abstract][Full Text] [Related]
30. Divergent FUS phosphorylation in primate and mouse cells following double-strand DNA damage.
Johnson MA; Deng Q; Taylor G; McEachin ZT; Chan AWS; Root J; Bassell GJ; Kukar T
Neurobiol Dis; 2020 Dec; 146():105085. PubMed ID: 32950644
[TBL] [Abstract][Full Text] [Related]
31. Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain.
Rogelj B; Easton LE; Bogu GK; Stanton LW; Rot G; Curk T; Zupan B; Sugimoto Y; Modic M; Haberman N; Tollervey J; Fujii R; Takumi T; Shaw CE; Ule J
Sci Rep; 2012; 2():603. PubMed ID: 22934129
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of β-catenin due to loss of miR-139 contributes to motor neuron death in amyotrophic lateral sclerosis.
Hawkins S; Namboori SC; Tariq A; Blaker C; Flaxman C; Dey NS; Henley P; Randall A; Rosa A; Stanton LW; Bhinge A
Stem Cell Reports; 2022 Jul; 17(7):1650-1665. PubMed ID: 35750046
[TBL] [Abstract][Full Text] [Related]
33. Sequestration of PRMT1 and Nd1-L mRNA into ALS-linked FUS mutant R521C-positive aggregates contributes to neurite degeneration upon oxidative stress.
Jun MH; Ryu HH; Jun YW; Liu T; Li Y; Lim CS; Lee YS; Kaang BK; Jang DJ; Lee JA
Sci Rep; 2017 Jan; 7():40474. PubMed ID: 28094300
[TBL] [Abstract][Full Text] [Related]
34. The
Yokoi S; Ito T; Sahashi K; Nakatochi M; Nakamura R; Tohnai G; Fujioka Y; Ishigaki S; Udagawa T; Izumi Y; Morita M; Kano O; Oda M; Sone T; Okano H; Atsuta N; Katsuno M; Okada Y; Sobue G
J Neurosci; 2022 Nov; 42(47):8881-8896. PubMed ID: 36261283
[TBL] [Abstract][Full Text] [Related]
35. Changes to the TDP-43 and FUS Interactomes Induced by DNA Damage.
Kawaguchi T; Rollins MG; Moinpour M; Morera AA; Ebmeier CC; Old WM; Schwartz JC
J Proteome Res; 2020 Jan; 19(1):360-370. PubMed ID: 31693373
[TBL] [Abstract][Full Text] [Related]
36. Pathogenic Mutation of TDP-43 Impairs RNA Processing in a Cell Type-Specific Manner: Implications for the Pathogenesis of ALS/FTLD.
Imaizumi K; Ideno H; Sato T; Morimoto S; Okano H
eNeuro; 2022; 9(3):. PubMed ID: 35641224
[TBL] [Abstract][Full Text] [Related]
37. Muscleblind acts as a modifier of FUS toxicity by modulating stress granule dynamics and SMN localization.
Casci I; Krishnamurthy K; Kour S; Tripathy V; Ramesh N; Anderson EN; Marrone L; Grant RA; Oliver S; Gochenaur L; Patel K; Sterneckert J; Gleixner AM; Donnelly CJ; Ruepp MD; Sini AM; Zuccaro E; Pennuto M; Pasinelli P; Pandey UB
Nat Commun; 2019 Dec; 10(1):5583. PubMed ID: 31811140
[TBL] [Abstract][Full Text] [Related]
38. Nuclear pore destruction and loss of nuclear TDP-43 in FUS mutation-related amyotrophic lateral sclerosis motor neurons.
Aizawa H; Teramoto S; Hideyama T; Kato H; Terashi H; Suzuki Y; Kimura T; Kwak S
J Neurol Sci; 2022 May; 436():120187. PubMed ID: 35232585
[No Abstract] [Full Text] [Related]
39. The role of TDP-43 mislocalization in amyotrophic lateral sclerosis.
Suk TR; Rousseaux MWC
Mol Neurodegener; 2020 Aug; 15(1):45. PubMed ID: 32799899
[TBL] [Abstract][Full Text] [Related]
40. Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations.
Alami NH; Smith RB; Carrasco MA; Williams LA; Winborn CS; Han SSW; Kiskinis E; Winborn B; Freibaum BD; Kanagaraj A; Clare AJ; Badders NM; Bilican B; Chaum E; Chandran S; Shaw CE; Eggan KC; Maniatis T; Taylor JP
Neuron; 2014 Feb; 81(3):536-543. PubMed ID: 24507191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
